ALEXANDRIA, Va., Jan. 29 -- United States Patent no. 12,209,126, issued on Jan. 28, was assigned to MEDIMMUNE Ltd. (Cambridge, Great Britain) and INNATE PHARMA (Marseilles, France).
"Treatment of cancer" was invented by Shaad Essa Abdullah (Gaithersburg, Md.), Ashok Kumar Gupta (Gaithersburg, Md.) and Xuyang Song (Gaithersburg, Md.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to the use of NKG2A-neutralizing agents and PD-1 neutralizing agents to treat cancers, notable cancers that are not characterized by DNA mismatch repair deficiency. Provided are methods of treatment of a cancer, as well as compositions and kits useful for treating a cancer that is not characterized by DNA...